|
|
|
|
| Symbol(s): |
ISPH |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
ISPH has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| ISPH has a current Overall Rating of C (Neutral). Power Rating (63) is high; appreciation potential (3) is negative. Relative to the S&P 500 Composite, Inspire Pharmaceuticals Inc has slightly more Value than Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. ISPH is of low investment quality. ISPH's current technical position is mixed. ISPH's Power Rating is 63. The recent trend in ISPH's earnings estimates has been extremely favorable. ...
| | |
|
|
